FOXO Technologies Inc. announced its agreement to acquire Vector Biosource Inc., a company specializing in information, data, and biospecimen sourcing for the biotechnology, clinical research, and pharmaceutical industries. The acquisition involves a purchase price comprising $500,000 in cash, 60,000 shares of Series E Cumulative Redeemable Secured Preferred Stock valued at $1.5 million, and warrants to buy $2 million of FOXO's common stock. An additional 80,000 Series E Preferred Stock shares, valued at up to $2 million, may be issued based on future revenue and cash collection milestones. FOXO plans to support Vector's growth initiatives with up to $1.2 million in funding. The acquisition is expected to close following the satisfaction of closing conditions.